Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êàðäèîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé êàðäèîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 16.11.2008, 19:50
LupusDoc LupusDoc âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 04.08.2007
Ãîðîä: RUSSIA
Ñîîáùåíèé: 4,176
Ïîáëàãîäàðèëè 1,091 ðàç(à) çà 998 ñîîáùåíèé
LupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLupusDoc ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Àíòèòðîìáîöèòàðíîå äåéñòâèå äèïèðèäàìîëà

Öèòàòà:
Ñîîáùåíèå îò Chevychelov Ïîñìîòðåòü ñîîáùåíèå
Âû íåïðàâèëüíî ìåíÿ ïîíÿëè. Ïðè áåðåìåííîñòè íåîáõîäèìî ïðèíèìàòü òîëüêî òå ïðåïàðàòû, êîòîðûå ïîêàçàíû. Åñòü ïîêàçàíèÿ è äëÿ àñïèðèíà ïðè áåðåìåííîñòè. Ó Âàñ ïðîñòî íåò òàêèõ ïîêàçàíèé.
ß áû íå áûë ñòîëü êàòåãîðè÷åí â îòíîøåíèè íåíóæíîñòè àñïèðèíà. Àñïèðèí â íàñòÿùåå âðåìÿ ÿâëÿåòñÿ íàèáîëåå ýôôåêòèâíûì ñðåäñòâîì ïðîôèëàêòèêè ãåñòîçà.
Ñóäÿ ïî îáðûâî÷íûì ñâåäåíèÿì î ïðîòåêàíèè ïåðâîé áåðåìåííîñòè ìîæíî ïðåäïîëîæèòü, ÷òî ïåðâàÿ áåðåìåííîñòü áûëà îñëîæíåíà ãåñòîçîì. Ãåñòîç âî âðåìÿ ïðåäøåñòâóþùåé áåðåìåííîñòè ÿâëÿåòñÿ ôàêòîðîì ðèñêà ðàçâèòèÿ ãåñòîçà â íàñòîÿùóþ áåðåìåííîñòü. Ïîýòîìó, ìîæåò áûòü, àñïèðèí íàçíà÷åí èìåííî ñ öåëüþ ïðîôèëàêòèêè ãåñòîçà.
Ðåêîìåíäóþ Âàì óòî÷íèòü ñ êàêîé èìåííî öåëüþ áûë íàçíà÷åí àñïèðèí.

Ïîêàçàíèé ê àíòèêîàãóëÿíòîé òåðàïèè äåéñòâèòåëüíî íå óñìàòðèâàåòñÿ.

Êîììåíòàðèè ê ñîîáùåíèþ:
Chevychelov îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 17.11.2008, 12:44
Àâàòàð äëÿ APTEM
APTEM APTEM âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.01.2007
Ãîðîä: Õàáàðîâñê
Ñîîáùåíèé: 610
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 33 ðàç(à) çà 29 ñîîáùåíèé
APTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìîæíî ïîïðîáîâàòü êóðàíòèë è íå ìîðî÷èòñÿ ñ ÿçâàìè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 17.11.2008, 14:11
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òîò êóðàíòèë, êîòîðûé ïðîäàåòñÿ â ÑÍà àáñîëþòíî íå îáëàäàåò àñïèðèíîïîäîáíûì äåéñòâèåì (ÿ ãîâîðþ î êàðäèîëîãèè, íå çíàþ ïðè ãåñòîçå - êîëëåãè ïîïðàâÿò). Ïðîëîíãèðîâàííûé êóðàíòèë (ïðîëîíãèðîâàííûé äèïèðèäàìîë) ïîêà íå ïîñòóïàåò â ÑÍÃ. Ïîýòîìó, íà ìîé âçãëÿä, àñïèðèí çàìåíèòü íå÷åì.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 17.11.2008, 15:32
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Chevychelov Ïîñìîòðåòü ñîîáùåíèå
Ìîæåòå ïîïðîáîâàòü 2 âàðèàíòà àñïèðèí êàðäèî 100 (êèøå÷íûé àñïìðìí), è îáû÷íûé àñïèðèí + îìåç 20 ìã íà íî÷ü. Åñëè ÷òî íå òàê, êîëëåãè ìåíÿ ïîïðàâÿò. Âîîáùåòî, ÿçâ áîëåçíü âíå îáîñòðåíèÿ íå ÿâëÿåòñÿ ïðîòèâîïîêàçàíèåì ê àñïèðèíó.
ß áû íåìíîæêî ïîïðàâèë - îìåç ýòî êàòåãîðèÿ Ñ ïðè áåðåìåííîñòè, åãî íåëüçÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 17.11.2008, 15:32
Àâàòàð äëÿ APTEM
APTEM APTEM âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.01.2007
Ãîðîä: Õàáàðîâñê
Ñîîáùåíèé: 610
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 33 ðàç(à) çà 29 ñîîáùåíèé
APTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Õì, óâàæàåìûé Ñåðãåé Ñåðãååâè÷, äèïèðèäàìîë îí è â Àôðèêå äèïèðèäàìîë. È íå ïðîëîíãèðîâàííûé, íè îáû÷íûé, äåéñòâèòåëüíî íå îáëàäàþò àñïèðèíîïîäîáíûì äåéñòâèåì. Ó äèïèðèäàìîëà, âèäèòå ëè äðóãîé ìåõàíèçì äåéñòâèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 17.11.2008, 16:18
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò APTEM Ïîñìîòðåòü ñîîáùåíèå
Õì, óâàæàåìûé Ñåðãåé Ñåðãååâè÷, äèïèðèäàìîë îí è â Àôðèêå äèïèðèäàìîë. È íå ïðîëîíãèðîâàííûé, íè îáû÷íûé, äåéñòâèòåëüíî íå îáëàäàþò àñïèðèíîïîäîáíûì äåéñòâèåì. Ó äèïèðèäàìîëà, âèäèòå ëè äðóãîé ìåõàíèçì äåéñòâèÿ.
Ðåêîìåíäàöèè ïî âòîðè÷íîé ïðîôèëàêòèêå - îáíîâëåíèå 2008 ãîäà
Ìîíîòåðàïèÿ àñïèðèíîì (50-325 ìã/äåíü) èëè àñïèðèí â ñî÷åòàíèè ñ äèïèðèäàìîëîì çàìåäëåííîãî âûñâîáîæäåíèÿ èëè ìîíîòåðàïèÿ êëîïèäîãðåëåì ÿâëÿþòñÿ äîïóñòèìûìè âàðèàíòàìè â êà÷åñòâå ñòàðòîâîé àíòèòðîìáîöèòàðíîé òåðàïèè*.
(Êëàññ I, Óðîâåíü äîêàçàííîñòè À.)
Ñî÷åòàíèå àñïèðèíà è äèïèðèäàìîëà çàìåäëåííîãî âûñâîáîæäåíèÿ ðåêîìåíäóåòñÿ êàê ïðåäïî÷òèòåëüíîå ê ìîíîòåðàïèè àñïèðèíîì.
(Êëàññ I, Óðîâåíü äîêàçàííîñòè B).
Íà îñíîâàíèè ðåçóëüòàòà èññëåäîâàíèÿ SPARKL, íàçíà÷åíèå ñòàòèíà ñ âûðàæåííûì ãèïîëèïèäåìè÷åñêèì äåéñòâèåì ðåêîìåíäîâàíî ó ïàöèåíòîâ ñ àòåðîñêëåðîòè÷åñêèì èíñóëüòîì èëè ÏÍÌÊ â àíàìíåçå íåçàâèñèìî îò íàëè÷èÿ èëè îòñóòñòâèÿ ÊÁÑ äëÿ ñíèæåíèÿ ðèñêà èíñóëüòà èëè ñåðäå÷íî-ñîñóäèñòûõ ñîáûòèé.
Êîíåö öèòàòû.

Âîò ýòî ÿ èìåë â âèäó (ìîæåò ÿ íåïðàâèëüíî âûðàçèëñÿ). Âïðî÷åì åñëè ãåñòîç ëå÷àò êóðàíòèëîì, òî îíî êîíå÷íî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 17.11.2008, 16:22
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íó òàê ýòî ïîòîìó, ÷òî "áûñòðûé" äèïèðèäàìîë - ýòî ñòðåññ-ÝÕÎ ñ äèïèðèäàìîëîì äëÿ ÈÁÑíèêà, íî áåç ÝÕÎ-ÊÃ
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 17.11.2008, 16:28
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Dr. Ïîñìîòðåòü ñîîáùåíèå
Íó òàê ýòî ïîòîìó, ÷òî "áûñòðûé" äèïèðèäàìîë - ýòî ñòðåññ-ÝÕÎ ñ äèïèðèäàìîëîì äëÿ ÈÁÑíèêà, íî áåç ÝÕÎ-ÊÃ
Âîïðîñ â òîì, îáëàäàåò áûñòðûé äèïèðèäàìîë àíòèòðîìáîöèòàðíûì äåéñòâèåì èëè íåò. Íàñêîëüêî ÿ çíàþ íåò, ïîýòîìó åãî íåò â ãàéäàõ. Ìîæåò ÿ íå îáëàäàþ íóæíîé èíôîðìàöèåé?
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 17.11.2008, 16:49
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàñêîëüêî ÿ çíàþ, êóðàíòèë â ïðîôèëàêòèêå ãåñòîçà èìååò êàêîé-òî âåñüìà ñëàáûé ýâèäåíñ. Êñòàòè íàïîìíþ, ÷òî äàííîé æåíùèíå íå òî ÷òîáû ãåñòîç ïðîôèëàêòèðóþò, à ñêîðåå äàæå ïðîñòî "ëå÷àò êîàãóëîãðàììó" Äà âîò ÷òî ÿ òóò íàøåë:

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Maternal outcomes
There was no overall difference in the risk of pregnancy induced hypertension in the 27 trials (18 147 women) reporting this outcome (relative risk 0.97, 95% confidence interval 0.89 to 1.05). The 15% reduction in risk of pre-eclampsia associated with antiplatelet drugs (32 trials, 29 331 women; relative risk 0.85 95% confidence interval 0.78 to 0.92; risk difference 0.01, 95% confidence interval 0.017 to 0.006; number needed to treat 100, 95% confidence interval 59 to 167) was consistent regardless of risk status (fig 2), dose of aspirin, gestation at trial entry, or use of a placebo. It was greater for women allocated >75 mg aspirin (relative risk 0.35, 0.24 to 0.52), but the numbers in this subgroup are small (13 trials, 1264 women).

There were no significant differences between treatment and control groups in the risk of eclampsia (nine trials, 14 623 women), maternal death (two trials, 9438 women), caesarean section (17 trials, 25 827 women), induction of labour (three trials, 15 935 women), antenatal admission (one trial, 6049 women), or placental abruption (12 trials, 22 309 women).

Outcomes for babies
In 23 trials (28 268 women) that reported preterm birth there was a small (8%) reduction in the risk of being born too early (relative risk 0.92, 0.88 to 0.97; risk difference 0.014, 0.023 to 0.005; number needed to treat 72, 44 to 200; fig 3). The size of this reduction was consistent across all subgroups, except those receiving >75 mg aspirin (557 women; relative risk 0.58, 0.38 to 0.88).

Ïî êóðàíòèëó òàì ìàëî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 17.11.2008, 16:51
Àâàòàð äëÿ APTEM
APTEM APTEM âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.01.2007
Ãîðîä: Õàáàðîâñê
Ñîîáùåíèé: 610
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 33 ðàç(à) çà 29 ñîîáùåíèé
APTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñåðãåé Ñåðãååâè÷, äîðîãîé. âû ìåíÿ ïðÿì óáèâàåòå. Ïî÷åìó âû ðåøèëè ÷òî îáû÷íûé äèïèðèäàìîë íå îáëàäàåò àíòèòðîìáîöèòàðíûì äåéñòâèåì? Íó íåëüçÿ æå òîëüêî ãàéäû ÷èòàòü. Âñå ðàâíî ÷òî ñêàçàòü, ÷òî ïðîëîíãèðîâàííûé ïåíèöèëëèí îáëàäàåò äåéñòâèåì íà òðåïîíåìó, à îáû÷íûé íåò.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Êóðàíòèë - äèïèðèäàìîë â ÑÍÃ. Ïåðñàíòèë - äèïèðèäàìîë â Åâðîïå. Àãðåíîêñ - Âàø ëþáèìûé ðåòàðäèðîâàííûé äèïèðèäàìîë â ñî÷åòàíèè ñ àñïèðèíîì.
À â ãàéäàõ îáû÷íîãî äèïèðèäàìîëà íåò, ïîòîìó ÷òî èññëåäîâàëñÿ ïðîëîíãèðîâàííûé, ïîòîìó ÷òî ñïîíñîðîì èññëåäîâàíèÿ âûñòóïàëà êîìïàíèÿ Áåðèíãåð, ïðîèçâîäÿùàÿ èìåííî àãðåíîêñ, ïîòîìó ÷òî..., âîò äîì, êîòîðûé ïîñòðîèë Äæåê (ñ)
Ïðîâîäÿòñÿ äåñÿòêè èññëåäîâàíèé ñ îáû÷íûì äèïèðèäàìîëîì.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
ß íå âñòðå÷àë ñðàâíèòåëüíûõ èññëåäîâàíèé, ïîêàçûâàþùèõ ïðåèìóùåñòâà ðåòàðäèðîâàííîãî äèïèðèäàìîëà íàä îáû÷íûì. Ìîæåò âû ïîäñêàæåòå?
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 17.11.2008, 17:08
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äèïèðèäàìîëà â êàðäèîëîãè÷åñêèõ ãàéäàõ íåò, çíà÷èò åãî íåò âîîáùå; ìíå õâàòàåò àñïèðèíà, êëîïè è äëèííîãî êóðàíòèëà. Âîò, êòî ìíå ñêàæåò àñïèðèí äëÿ ïðîôèëàêòèêè ãåñòîçà òîæå íå èç ãàéäîâ, à èç îïûòà ìîñêîâñêîãî ðîääîìà ¹2?
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 17.11.2008, 17:38
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Åñòü îïðåäåëåííîå ïîäîçðåíèå, ÷òî êîðîòêèé êóðàíòèë âî-ïåðâûõ íåäîëãî äåéñòâóåò, à âî-âòîðûõ - áîëåå àêòèâíî âûçûâàåò àðòåðèîëîäèëàòàöèþ è ôåíîìåí îáêðàäûâàíèÿ ó áîëüíûõ ñ èøåìè÷åñêîé áîëåçíü ñåðäöà. Îò îòñóòñòâèÿ àããðåíîêñà ìíîãèå ëþäè ó íàñ â ñòðàíå ñòðàäàþò - âñåì õî÷åòñÿ åáýýìíî ïðîôèëàêòèðîâàòü èíñóëüò ïðîâåðåííîé ðåòàðäíîé êîìáèíàöèåé, äà âîò íå ïîëó÷àåòñÿ (ñì. öèòàòó îò Ñåðãåÿ Ñåðãååâè÷à).
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 17.11.2008, 17:50
Àâàòàð äëÿ APTEM
APTEM APTEM âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.01.2007
Ãîðîä: Õàáàðîâñê
Ñîîáùåíèé: 610
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 33 ðàç(à) çà 29 ñîîáùåíèé
APTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Antiplatelet therapy, in particular, low dose (< 75 mg) aspirin, reduces the risk of pre-eclampsia by around 15% for women at both low and high risk. There appears to be a similar reduction in the risk of perinatal death. Aspirin should be considered, particularly for women at high risk. In countries with a high prevalence of pre-eclampsia, more widespread use may be worthwhile. (Grade B)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ìîæíî è ïîíîâåå íàéòè, ëåíü
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 17.11.2008, 17:59
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò APTEM Ïîñìîòðåòü ñîîáùåíèå
Antiplatelet therapy, in particular, low dose (< 75 mg) aspirin, reduces the risk of pre-eclampsia by around 15% for women at both low and high risk. There appears to be a similar reduction in the risk of perinatal death. Aspirin should be considered, particularly for women at high risk. In countries with a high prevalence of pre-eclampsia, more widespread use may be worthwhile. (Grade B)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ìîæíî è ïîíîâåå íàéòè, ëåíü
Ïðî 15% ÿ ÷åòûðüìÿ ïîñòàìè ðàíüøå ïèñàë, âîïðîñ òîëüêî â òîì, äåéñòâèòåëüíî ëè "Ìîæíî ïîïðîáîâàòü êóðàíòèë è íå ìîðî÷èòñÿ ñ ÿçâàìè", èáî òóò ïðî àñïèðèí, à òðàéëîâ ïî äèïè- - ôèã äà ìàëåíüêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 17.11.2008, 18:13
Àâàòàð äëÿ Chevychelov
Chevychelov Chevychelov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 09.09.2006
Ãîðîä: Òèðàñïîëü
Ñîîáùåíèé: 2,244
Ñêàçàë(à) ñïàñèáî: 73
Ïîáëàãîäàðèëè 163 ðàç(à) çà 140 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 54
Chevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåChevychelov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èçâèíèòå ìû ñàìè íå ìåñòíûå è ìàëîìàëîãðàìîòíûå, à ÷òî ïðåýêëàìïñèÿ è ãåñòîç (ïîçäíèå òîêñèêîçû) îäíî è òî æå?
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 06:50.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.